Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Finasteride increases risk of sleep apnea and insomnia.

Gut flora changes could potentially indicate depression, but more research is needed.

Sebum production varies by individual and is influenced by age, gender, and hormones, affecting skin and hair health.

Advancements in hair follicle culture have led to better understanding and potential treatments for hair loss.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

Pranlukast and mirabegron may work as new diabetes drugs.

The document is a detailed medical reference on skin and genetic disorders.

Most adult women with PCOS in Port Harcourt, Nigeria, have high levels of bad fats in their blood, especially younger women.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Ovol2 is crucial for hair growth and skin healing by controlling cell movement and growth.

Men with severe hair loss may have a higher risk of heart disease.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Lactate production is important for activating hair growth stem cells.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Stem cell niches support, regulate, and coordinate stem cell functions.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.